The Microbial Engineering community has made extraordinary progress toward developing a number of promising vaccine candidates to provide proection against COVID-19. This January 26 webinar, sponsored by Engineering Conferences International (ECI), will focus on a variety of programs based either on microbial platforms or cell gree synthesis.
ECI a not for profit global engineering conferences program originally established in 1962, that provides for the exploration of problems and issues of concern to engineers and scientists from many disciplines.
Webinar Information: January 26, 2021
10 am - 12:30 pm US Eastern Standard Time
Registration: engconf.us/eci-conference-on-microbial-engineering-webinar/
The confirmed speakers include:
John Liddell (CPI-Centre for Process Innovation), UK)
"Microbial technology supporting Covid-19 vaccine development"
Kathrin Jansen (Pfizer, USA)
"Learnings from the development of a Covid-19 vaccine"
Virkram Paradkar (Biological E, India)
"Development of Covid-19 vaccine based on receptor binding domain from spike protein of SARS-CoV-2"
Ronen Tschelet (Dyadic Intl., USA)
"C1 - A low cost production platform to combat Covid-pandemic"
Andrey Zarur (Greenlight Biosciences, USA)
"Scaling cell free synthesis of mRNA to enable global herd immunity through Covid-19 vaccine"
Robert Juba, Jr (Inovio, USA)
"Leveraging a plasmid DNA platform for Covid-19 vaccine development"
Mark Bodmer (EVELO, USA)
"From worms to the small intestinal axis - A new approach to resolving systemic inflammation caused by Covid-19"
###